ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Adverse effects"

  • 2021 American Transplant Congress

    Systematic Evaluation of Immunosuppressant Drug Tolerability in Lung Transplant Recipients with Short Telomere Syndrome

    R. Patolia1, R. Guzy2, L. Potter1

    1Department of Pharmacy, University of Chicago Medicine, Chicago, IL, 2Department of Medicine, Division of Pulmonology, University of Chicago Medicine, Chicago, IL

    *Purpose: Lung transplant recipients with short telomere syndrome are at high risk of hematologic complications. Consequently, patients with short telomere syndrome may require more frequent…
  • 2021 American Transplant Congress

    Economic Impact of a Pharmacist-Led Medication Safety Intervention: Report from the Transafe Rx Randomized Controlled Trial

    D. Taber, J. Fleming, Z. Su, P. Mauldin, M. Gebregziabher

    Med Univ of South Carolina, Charleston, SC

    *Purpose: We have previously demonstrated the efficacy of a pharmacist-led, mHealth intervention on reducing medication errors and adverse events leading to reduce hospitalizations in kidney…
  • 2021 American Transplant Congress

    Short Term Outcomes in Previously Covid Positive Kidney Transplant Recipients in Pre-vaccine Era

    R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel

    Henry Ford Transplant Institute, Detroit, MI

    *Purpose: To study clinical characteristics and short-term outcomes in kidney transplant recipients who were previously infected with SARS-CoV-2*Methods: In this retrospective, single-center case-series, we identified…
  • 2021 American Transplant Congress

    Reduction in Medication Errors at Discharge in the Transplant Population via Use of Novel Pharmacist / Nursing Dual Check System

    M. Norris, S. Witek, C. Whritenour, K. Sigafus, C. Chiang, C. Sammons, D. Naveiro, A. Paredes, E. Perez-Ngai, M. Kaminski, R. Westmoreland, G. Malat

    Hospital of the University of Pennsylvania, Philadelphia, PA

    *Purpose: Medication errors are of great concern due to the risk for patient and allograft injury. The aim of this study was to evaluate the…
  • 2021 American Transplant Congress

    Association of Immune Cell Markers with Adverse Outcomes in the First 6 Months Post-pediatric Heart Transplantation

    J. Chen1, D. Salerno2, H. Corbo1, S. Shah3, A. Rothkopf4, I. D. Lytrivi4

    1Department of Pharmacy, Columbia University Irving Medical Center, New York, NY, 2Department of Pharmacy, Weill Cornell Medical Center, New York, NY, 3College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 4Pediatric Cardiology, Columbia University Irving Medical Center, New York, NY

    *Purpose: Immunosuppression titration post-orthotopic heart transplant (OHT) is limited to trough level monitoring and does not provide data pertaining to overall state of immunosuppression. Additional…
  • 2021 American Transplant Congress

    Association Between Cumulative Antithymocyte Globulin Dosing and Adverse Outcomes in Pediatric Heart Transplant Recipients

    J. Chen1, D. Salerno1, H. Corbo1, S. Shah2, A. Rothkopf3, I. D. Lytrivi3

    1Department of Pharmacy, NewYork-Presbyterian Hospital, New York, NY, 2College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 3Pediatric Cardiology, Columbia University Irving Medical Center, New York, NY

    *Purpose: Lymphocyte depletion via rabbit antithymocyte globulin (rATG) is the most frequently used induction immunosuppressive in pediatric orthotopic heart transplant (OHT). Although outcomes are often…
  • 2021 American Transplant Congress

    Beta-lactam Allergies Among Solid Organ Transplant Recipients: Prevalence and Association with Transplant Admission Length of Stay

    N. N. Pettit1, V. Nguyen2, C. T. Nguyen1, A. Lew1, J. Pisano1, L. M. Potter1

    1University of Chicago Medicine, Chicago, IL, 2University of Michigan College of Pharmacy, Ann Arbor, MI

    *Purpose: Previous studies have identified that 14-27% of solid organ transplant (SOT) recipients report a beta lactam allergy (BLA). Patients with BLAs often receive less…
  • 2021 American Transplant Congress

    Impact of Pre- and Post-transplant Outcomes on Patient-reported Outcomes in a Prospective Multicenter Trial in Kidney Transplantation

    J. M. Rohan1, J. P. Leone2, E. Woodle3, D. Kaufman4, A. R. Shields3, A. Wiseman5, A. J. Matas6, P. West-Thielke7, E. King3, R. R. Alloway3

    1Children's Hospital Richmond VCU, Richmond, VA, 2Tampa General, Tampa, FL, 3U Cincinnati, Cincinnati, OH, 4U Wisconsin, Madison, WI, 5Centura Transplant, Denver, CO, 6U Minnesota, Minneapolis, MN, 7UIC, Chicago, IL

    *Purpose: BEST Trial (Belatacept-based Early Steroid-withdrawal Trial) compared belatacept (BELA)-based early steroid withdrawal (ESW) regimens with a tacrolimus (TAC)-based ESW regimen across 2years. CNI free/ESW…
  • 2021 American Transplant Congress

    Predictors of Postoperative Atrial Fibrillation in an Urban, Obese Adult Renal Transplant Population

    A. Lichvar, Z. Ress, M. Tabriz, H. Jenkins, T. Walsh, I. Tzvetanov, E. Benedetti, M. Campara

    University of Illinois at Chicago, Chicago, IL

    *Purpose: Postoperative atrial fibrillation (POAF) is a common surgical complication. Renal transplant (RT) recipients possess risk factors that may lead to a higher incidence of…
  • 2021 American Transplant Congress

    Tolerability of De Novo and Conversion Belatacept Regimens in Kidney Transplantation

    T. Le1, J. Shoji2, J. Phillips1, D. Quan1

    1Pharmaceutical Services, UCSF Medical Center, San Francisco, CA, 2Transplant Nephrology, UCSF Medical Center, San Francisco, CA

    *Purpose: Belatacept, a selective T lymphocyte co-stimulation blocker, has been shown to be a safe and effective maintenance therapy for immunosuppression. We investigated the long-term…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 18
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences